Biotech stock with a focus on repairing degenerative illness.
IPO’d this year at $13 dollars up to around $18 at the moment. Have a drug for a hearing loss currently in second phase testing with fast-track status with the FDA. Very unique treatment.
Results due Q2/2020 - could be a big multi bagger if it passes.
Information on stock, financials, earnings, subsidiaries, investors, and executives for Frequency Therapeutics. Use the PitchBook Platform to explore the full profile.
Another request available on Revolut and in fractions if required. I’m using both for platforms for now.
We need a new batch of new stocks delivered for sure
Even better now - hit $40 this week!
I saw this as a small speculative bet, but now that I know it has real legs I may make it a sizeable position if the price is right and there are positive preliminary results from the study of their first therapy.